| Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study M Peyrot, AH Barnett, LF Meneghini, PM Schumm‐Draeger Diabetic Medicine 29 (5), 682-689, 2012 | 744 | 2012 |
| Lower within‐subject variability of fasting blood glucose and reduced weight gain with insulin detemir compared to NPH insulin in patients with type 2 diabetes T Haak, A Tiengo, E Draeger, M Suntum, W Waldhäusl Diabetes, Obesity and Metabolism 7 (1), 56-64, 2005 | 425 | 2005 |
| Albumin‐bound basal insulin analogues (insulin detemir and NN344): comparable time‐action profiles but less variability than insulin glargine in type 2 diabetes O Klein, J Lynge, L Endahl, B Damholt, L Nosek, T Heise Diabetes, Obesity and Metabolism 9 (3), 290-299, 2007 | 341 | 2007 |
| The efficacy and safety of insulin degludec given in variable once-daily dosing intervals compared with insulin glargine and insulin degludec dosed at the same time daily: a 26 … L Meneghini, SL Atkin, SCL Gough, I Raz, L Blonde, M Shestakova, ... Diabetes care 36 (4), 858-864, 2013 | 339 | 2013 |
| Patient‐directed titration for achieving glycaemic goals using a once‐daily basal insulin analogue: an assessment of two different fasting plasma glucose targets‐the TITRATETM … L Blonde, M Merilainen, V Karwe, P Raskin, TITRATE™ Study Group Diabetes, Obesity and Metabolism 11 (6), 623-631, 2009 | 265 | 2009 |
| Insulin degludec in type 1 diabetes: a randomized controlled trial of a new-generation ultra-long-acting insulin compared with insulin glargine KI Birkeland, PD Home, U Wendisch, RE Ratner, T Johansen, LA Endahl, ... Diabetes care 34 (3), 661-665, 2011 | 223 | 2011 |
| The usage of a simplified self‐titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes–results of the randomized, controlled PREDICTIVE … L Meneghini, C Koenen, W Weng, JL Selam Diabetes, Obesity and Metabolism 9 (6), 902-913, 2007 | 184 | 2007 |
| Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin … LF Meneghini, KH Rosenberg, C Koenen, MJ Merilainen, HJ Lüddeke Diabetes, Obesity and Metabolism 9 (3), 418-427, 2007 | 183 | 2007 |
| Factors associated with injection omission/non‐adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study M Peyrot, AH Barnett, LF Meneghini, PM Schumm‐Draeger Diabetes, Obesity and Metabolism 14 (12), 1081-1087, 2012 | 175 | 2012 |
| Obesity, bariatric surgery and type 2 diabetes—a systematic review CV Ferchak, LF Meneghini Diabetes/metabolism research and reviews 20 (6), 438-445, 2004 | 175 | 2004 |
| Screening, evaluation and management of depression in people with diabetes in primary care N Hermanns, S Caputo, G Dzida, K Khunti, LF Meneghini, F Snoek Primary care diabetes 7 (1), 1-10, 2013 | 143 | 2013 |
| Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in E urope and the USA D Mauricio, L Meneghini, J Seufert, L Liao, H Wang, L Tong, A Cali, ... Diabetes, Obesity and Metabolism 19 (8), 1155-1164, 2017 | 140 | 2017 |
| Study of Once Daily Levemir (SOLVE™): insights into the timing of insulin initiation in people with poorly controlled type 2 diabetes in routine clinical practice K Khunti, T Damci, L Meneghini, CY Pan, JF Yale, SOLVE Study Group Diabetes, Obesity and Metabolism 14 (7), 654-661, 2012 | 140 | 2012 |
| Perioperative management of diabetes: translating evidence into practice. LF Meneghini Cleveland clinic journal of medicine 76, S53-9, 2009 | 116 | 2009 |
| An electronic case manager for diabetes control LF Meneghini, AM Albisser, RB Goldberg, DH Mintz Diabetes care 21 (4), 591-596, 1998 | 115 | 1998 |
| Weight beneficial treatments for type 2 diabetes LF Meneghini, D Orozco-Beltran, K Khunti, S Caputo, T Damci, A Liebl, ... The Journal of Clinical Endocrinology & Metabolism 96 (11), 3337-3353, 2011 | 107 | 2011 |
| Insulin detemir improves glycaemic control without weight gain in insulin‐naïve patients with type 2 diabetes: subgroup analysis from the PREDICTIVETM study A Dornhorst, HJ Lüddeke, S Sreenan, P Kozlovski, JB Hansen, BJ Looij, ... International journal of clinical practice 62 (4), 659-665, 2008 | 107 | 2008 |
| Barriers to initiating insulin in type 2 diabetes patients: development of a new patient education tool to address myths, misconceptions and clinical realities M Brod, SL Alolga, L Meneghini The Patient-Patient-Centered Outcomes Research 7, 437-450, 2014 | 101 | 2014 |
| Comparison of 2 intensification regimens with rapid-acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral … L Meneghini, H Mersebach, S Kumar, AL Svendsen, K Hermansen Endocrine Practice 17 (5), 727-736, 2011 | 99 | 2011 |
| Efficacy and safety of ezetimibe co‐administered with simvastatin in thiazolidinedione‐treated type 2 diabetic patients LM Gaudiani, A Lewin, L Meneghini, I Perevozskaya, D Plotkin, Y Mitchel, ... Diabetes, Obesity and metabolism 7 (1), 88-97, 2005 | 97 | 2005 |
Kamlesh KhuntiProfessor of Primary Care Diabetes and Vascular Medicine, University of Leicester在 le.ac.uk 的电子邮件经过验证
